www.verygoodnewsisrael.blogspot.com
ISRAEL’S MEDICAL ACHIEVEMENTS
More patients to receive Covid-19 treatment. Israel’s Pluristem (reported here previously) has launched an FDA-cleared Covid-19 expanded access program. It enables Pluristem to use its PLX-PAD cells to treat up to 100 more infected patients outside its current trials in the USA and Europe and compassionate use in Israel.
https://www.pluristem.com/wp-content/uploads/2020/08/PSTI-Expanded-Access-Program-last-version.pdf
Maintaining Covid-19 antibodies. Israel’s Elicio Therapeutics has published the results of a pre-clinical study of its ELI-005 protein subunit vaccine for Covid-19. It extended the life of coronavirus antibodies and may resolve the problem whereby patients who recover from the virus can be re-infected if later exposed to it.
https://jewishbusinessnews.com/2020/08/24/israeli-startup-elicio-therapeutics-fights-covid-19-with-immunotherapy/ https://elicio.com/
Breath test for Covid-19. Technion’s Hossam Haick, the Israeli-Arab Professor who invented the Sniffphone cancer detector (reported here previously) has led the development of another Israeli coronavirus breathalyzer test (see here for previous). The rest of his team is in Wuhan, China where Covid-19 likely originated.
https://jewishbusinessnews.com/2020/08/23/breathalyzer-tests-for-corona-virus-israel-scientists-say-yes/
https://pubs.acs.org/doi/abs/10.1021/acsnano.0c05657
UK uses Israeli colon cancer risk software. (TY Hazel) Barts Health, one of the largest providers to the UK’s National Health Service, has selected the ColonFlag software from Israel’s Medial EarlySign (reported here previously) to identify members at high risk for developing colon cancer – the UK’s 4th most common cancer.
https://www.timesofisrael.com/uks-barts-health-to-use-israeli-tech-to-flag-patients-at-risk-for-colon-cancer/
Stimulating the brain to help quit smoking. The US FDA has approved the use of the Deep Transcranial Magnetic Stimulation (TMS) system from Israel’s BrainsWay (see here) to treat cigarette smokers who seek to quit. The patient wears a helmet containing a patented H-coil that generates a magnetic field for 20-minutes.
https://www.calcalistech.com/ctech/articles/0,7340,L-3846389,00.html
First delivery of burns treatment. Israel’s Mediwound (reported here previously) has delivered its first batch of its Nexobrid treatment for burns to BARDA (the Biomedical Advanced Research and Development Authority) for the US Department of Health’s emergency response preparedness.
http://ir.mediwound.com/news-releases/news-release-details/mediwound-and-vericel-announce-acceptance-first-delivery
DayTwo wins Roche Diabetes Care Innovation contest. Israel’s DayTwo (reported here previously) won the 2020 Roche Diabetes Care Innovation Contest. Its virtual pitch convinced the judges that its personalized nutrition solution, using microbiome data, could best integrate with Roche Diabetes Care.
https://www.israel21c.org/daytwo-wins-roche-diabetes-care-innovation-contest/
https://www.youtube.com/watch?v=L_n3H8XlIGo
The patient room of 2030. (TY Stuart Pl) This video simulates how the futuristic patient rooms at Israel’s Sheba hospital integrate artificial intelligence, robotic technologies, wearable devices, virtual reality and other smart technology to simulate the most extreme medical situations, including the current coronavirus pandemic.
https://www.youtube.com/watch?v=fdQEVGHP3NE